i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19

Dec 21, 2022

Time to read 4 Minutes

Download PDF

Back